Literature DB >> 19194193

The Gist of literature on pediatric GIST: review of clinical presentation.

D A Kaemmer1, J Otto, L Lassay, G Steinau, C Klink, K Junge, U Klinge, V Schumpelick.   

Abstract

AIM/
BACKGROUND: To provide a review of existing literature on pediatric GIST with focus on clinical presentation.
METHODS: A MEDLINE search was conducted in July 2007 to give an overview on literature concerning pediatric gastrointestinal stromal tumors (GISTs) with a focus on clinical presentation, using keywords "gastrointestinal stromal tumor" and one of the following "young/boy/girl/child/children/pediatric." Two of the authors sorted the resulting abstracts by relevance for a review on clinical aspects of pediatric GIST if they were in English language, not explicitly only reporting of adults and describing clinical features of patients.
RESULTS: One hundred and six articles were found, 43 of which were excluded because they did not match the criteria mentioned above. We found 97 patients in the articles meeting our criteria, of which 38 cases had to be excluded, because of lacking clinical data, negative staining for CD117 or syndromal occurrence. This left 59 patients for analysis of clinical symptoms in the presentation of nonsyndromal CD117-positive GIST in children. DISCUSSION: Clinical feature most frequent was anemia in 86.4% (n=51) symptomatic either through acute or subacute bleeding. There was no palpable tumor in 88.1% (n=52), no abdominal pain in 84.7% (n=50), and no vomiting in 88.1% (n=52). Girls tend to show more high-grade tumors and existing case reports show a 2.7-fold higher incidence in females. Altogether epithelioid cell tumors are most frequent, although in boys spindle-cell tumors are reported more often. On the basis of National Institute of Health criteria (6) tumors were low grade in 22% (n=13), medium grade in 37.3% (n=22), and high grade in 35.6% (n=21). There were more high-grade tumors in girls than in boys (40.5% vs. 28.6%). Local excision was the operation most often performed, but details of surgery were missing in most cases.
CONCLUSIONS: Pediatric GIST is a rare but considerable diagnosis in chronic anemia, which is the most frequent clinical finding with this tumor entity. Recent review articles focus on histopathologic criteria but omit clinical features and course of disease. In nonsyndromal CD117-positive GIST, girls tend to show more high-grade tumors and existing literature on pediatric GIST shows a 2.7-fold higher incidence in females. Altogether epithelioid cell tumors are most frequent, although in boys spindle-cell tumors are reported more often. Together with known differences in molecular changes and local as well as systemic tumor behavior this strongly suggests that pediatric GIST represents a different entity than adult GIST. After establishment of clear-cut pathologic features in the past, reports on preoperative diagnostic findings, long-term follow-up, and therapy have to be emphasized to clarify the relationship of these entities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194193     DOI: 10.1097/MPH.0b013e3181923cd8

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  12 in total

1.  Gastrointestinal stromal tumor: psychosocial characteristics and considerations.

Authors:  Lori Wiener; Haven Battles; Sima Zadeh; Carly J Smith; Lee J Helman; Su Young Kim
Journal:  Support Care Cancer       Date:  2012-03-17       Impact factor: 3.603

Review 2.  Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches.

Authors:  Su Y Kim; Katherine Janeway; Alberto Pappo
Journal:  Curr Opin Oncol       Date:  2010-07       Impact factor: 3.645

3.  Gastric adenocarcinoma in children and adolescents.

Authors:  Vivek Subbiah; Gauri Varadhachary; Cynthia E Herzog; Winston W Huh
Journal:  Pediatr Blood Cancer       Date:  2011-01-24       Impact factor: 3.167

Review 4.  Usual and unusual causes of pediatric gastric outlet obstruction.

Authors:  Jeffrey P Otjen; Ramesh S Iyer; Grace S Phillips; Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2012-03-29

Review 5.  Gastrointestinal stromal tumors of the small intestine in pediatric populations: a case report and literature review.

Authors:  Manabu Shimomura; Satoshi Ikeda; Yuji Takakura; Yasuo Kawaguchi; Masakazu Tokunaga; Haruka Takeda; Daisuke Sumitani; Masanori Yoshimitsu; Takao Hinoi; Masazumi Okajima; Hideki Ohdan
Journal:  Pediatr Surg Int       Date:  2010-04-21       Impact factor: 1.827

6.  Carney triad, SDH-deficient tumors, and Sdhb+/- mice share abnormal mitochondria.

Authors:  Eva Szarek; Evan R Ball; Alessio Imperiale; Maria Tsokos; Fabio R Faucz; Alessio Giubellino; François-Marie Moussallieh; Izzie-Jacques Namer; Mones S Abu-Asab; Karel Pacak; David Taïeb; J Aidan Carney; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2015-03-25       Impact factor: 5.678

7.  Incidental GIST after appendectomy in a pediatric patient: a first instance and review of pediatric patients with CD117 confirmed GISTs.

Authors:  Sifrance Tran; Michael Dingeldein; Sarah C Mengshol; Saundra Kay; Anthony C Chin
Journal:  Pediatr Surg Int       Date:  2013-11-30       Impact factor: 1.827

Review 8.  Current treatment strategies in pediatric gastrointestinal stromal cell tumor.

Authors:  Brent A Willobee; Hallie J Quiroz; Matthew S Sussman; Chad M Thorson; Juan E Sola; Eduardo A Perez
Journal:  Transl Gastroenterol Hepatol       Date:  2018-08-08

Review 9.  Small intestinal gastrointestinal stromal tumor in a young adult woman: a case report and review of the literature.

Authors:  Suzana Manxhuka-Kerliu; Vjollca Sahatciu-Meka; Irma Kerliu; Argjira Juniku-Shkololli; Lloreta Kerliu; Mevlyde Kastrati; Vesa Kotorri
Journal:  J Med Case Rep       Date:  2014-09-28

10.  Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST).

Authors:  Klaus Kramer; Uwe Knippschild; Benjamin Mayer; Kira Bögelspacher; Hanno Spatz; Doris Henne-Bruns; Abbas Agaimy; Matthias Schwab; Michael Schmieder
Journal:  BMC Cancer       Date:  2015-02-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.